PhD Graduate Education at Northeastern University logo
PhD Graduate Education at Northeastern University logo
  • PhD Programs
  • Partnerships
  • Research Scholars
  • PhD Network
    • Overview
    • Resources
    • New Students
    • Opportunities
    • Experiential PhD
    • Global PhD
    • Feedback
  • News
  • Calendar
Opportunity

A-T Children’s Project Research Grant Program and Awards

Deadline: Continuous

The A-T Children’s Project supports promising research with sound scientific rationale. No idea is too novel for us to consider, as long as it has clear relevance for people with ataxia telangiectasia (A-T) and the potential to lead to a therapy. We are open to creative ideas conceived by investigators. From time to time, we also encourage projects that address a specific gap in scientific understanding, patient need or therapeutic development. In addition, we sometimes provide add-on, supplemental funding if a grant we already awarded shows significant progress and continued potential.

While the A-T Children’s Project has previously granted millions of dollars to support projects aimed at elucidating A-T biology, we are now focusing our limited funds on experiments whose success will provide a clear path to a treatment or intervention for A-T. For example, we are enthusiastic about exploring new DNA-based modalities that may cause a working ATM protein to be produced in the cerebella of people with A-T, or testing compounds that have a strong mechanistic hypothesis for having efficacy in a patient with A-T. We are also eager to support the development of biomarkers and digital tools that could improve and accelerate clinical development for A-T.

Duration

1-2 years

Funding

Upper:  $150,000USD

One and two-year projects are funded up to a maximum total direct cost of $75,000 per year. In rare instances, if a project involves the later phases of developing a therapy, we may consider a larger budget for which we would create a specific fundraising campaign.
Eligibility

We welcome applications from academia and industry scientists, small biotechnology and large pharmaceutical companies, and even from venture capital firms that are incubating new technologies which may hold promise for A-T. Our portfolio spans basic, translational and clinical research. Junior investigators are particularly encouraged to apply for grants, as we are eager to bring new people into the A-T research field who may commit their career and labs to this disease long into the future. We welcome fresh insights.

  • Website
  • Contact

    [email protected]